Business
ASX 200 rises 0.6%, Mesoblast soars – Motley Fool Australia
The S&P/ASX 200 Index (ASX:XJO) rose by another 0.6% today. The Mesoblast Limited (ASX:MSB) share price jumped 39% higher.
The S&P/ASX 200 Index (ASX: XJO) rose by around 0.6% today to 6,126 points.
The biggest rise of the day didn’t belong to an ASX share announcing a report:
Mesoblast Limited (ASX: MSB) takes off
A very positive US announcement sent the Mesoblast share price up 39% today.
The ASX 200 company said that Oncological Drugs Advisory Committee (ODAC) of the United States Food and Drug Administration (FDA) voted in favour that the available data supports the efficacy of remestemcel-L (RYONCIL) in…
-
Business9 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General21 hours agoDonald Trump and the ghost of Al Capone • Inside Story